For research use only. Not for therapeutic Use.
Heptakis-6-iodo-6-deoxy-beta-cyclodextrin(Cat No.:L016199)is a chemically modified cyclodextrin derivative where the hydroxyl groups at the 6-position of the glucose units are replaced with iodine atoms. This compound is used in pharmaceutical and chemical research for its unique ability to form inclusion complexes with various guest molecules, enhancing the solubility and stability of poorly soluble drugs. The iodine substitution provides additional functionalization opportunities, making it valuable for drug delivery systems, diagnostic imaging, and other applications requiring molecular encapsulation and targeted delivery. Its modified structure also allows for specialized uses in material science and bioconjugation.
Catalog Number | L016199 |
CAS Number | 30754-23-5 |
Molecular Formula | C42H63I7O28 |
Purity | ≥95% |
IUPAC Name | (1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-heptakis(iodomethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol |
InChI | InChI=1S/C42H63I7O28/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51/h8-42,50-63H,1-7H2/t8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m1/s1 |
InChIKey | YODKQJPYQJRHEQ-FOUAGVGXSA-N |
SMILES | C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)CI)CI)CI)CI)CI)CI)O)O)I |